Denali Therapeutics
DNLI
DNLI
194 hedge funds and large institutions have $2.24B invested in Denali Therapeutics in 2023 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 77 increasing their positions, 57 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 36
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
29% less capital invested
Capital invested by funds: $3.18B → $2.24B (-$938M)
Holders
194
Holding in Top 10
3
Calls
$2.06M
Puts
$697K
Top Buyers
| 1 | +$17.3M | |
| 2 | +$16.1M | |
| 3 | +$15.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.32M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$6.36M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$11.4M | |
| 3 | -$10.5M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$8.34M |
| 5 |
Millennium Management
New York
|
-$7.42M |